Vaccine effectiveness of BNT162b2 against Delta and Omicron variants in adolescents
Buchan SA, Nguyen L, Wilson SE, Kitchen SA, Kwong JC. Pediatrics. 2022; Jun 16 [Epub ahead of print].
Publications
Background incidence rates of adverse events of special interest related to COVID-19 vaccines in Ontario, Canada, 2015 to 2020, to inform COVID-19 vaccine safety surveillance
Nasreen S, Calzavara A, Buchan SA, Thampi N, Johnson C, Wilson SE, Kwong JC; on behalf of the Canadian Immunization Research Network CIRN Provincial Collaborative Network PCN Ontario investigators. Vaccine. 2022; 40(24):3305-12. Epub 2022 Apr 27.
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario
Nasreen S, Chung H, He S, Brown KA, Gubbay JB, Buchan SA, Fell DB, Austin PC, Schwartz KL, Sundaram ME, Calzavara A, Chen B, Tadrous M, Wilson K, Wilson SE, Kwong JC; Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. Nat Microbiol. 2022; 7(3):379-85. Epub 2022 Feb 7.
Background incidence rates of hospitalisations and emergency department visits for thromboembolic and coagulation disorders in Ontario, Canada for COVID-19 vaccine safety assessment: a population-based retrospective observational study
Nasreen S, Calzavara AJ, Sundaram ME, MacDonald SE, Righolt CH, Pai M, Field TS, Zhou LW, Wilson SE, Kwong JC. BMJ Open. 2021; 11(12):e052019. Epub 2021 Dec 17.
Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002–2018: a Canadian Immunization Research Network (CIRN) study
Nasreen S, Wang J, Kwong JC, Crowcroft NS, Sadarangani M, Wilson SE, McGeer A, Kellner JD, Quach C, Morris SK, Sander B, Kus JV, Naus M, Hoang L, Rudzicz F, Fadel S, Marra F. Vaccine. 2021; 39(52):7545-53. Epub 2021 Nov 19.
Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study
Chung H, He S, Nasreen S, Sundaram ME, Buchan SA, Wilson SE, Chen B, Calzavara A, Fell DB, Austin PC, Wilson K, Schwartz KL, Brown KA, Gubbay JB, Basta NE, Mahmud SM, Righolt CH, Svenson LW, MacDonald SE, Janjua NZ, Tadrous M, Kwong JC; on behalf of the Canadian Immunization Research Network (CIRN) Provincial Collaborative Network (PCN) Investigators. BMJ. 2021; 374:n1943. Epub 2021 Aug 20.
Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments
Sundaram M, Nasreen S, Calzavara A, He S, Chung H, Bronskill SE, Buchan SA, Tadrous M, Tanuseputro P, Wilson K, Wilson S, Kwong JC; Canadian Immunization Research Network (CIRN) investigators. Vaccine. 2021; 39(37):5265-70. Epub 2021 Jul 23.
Vaccine coverage among children with epilepsy in two Canadian provinces: a Canadian immunization research network study
Righolt CH, Pabla G, Donelle J, Brna P, Deeks SL, Wilson SE, Smith B, Wilson K, Mahmud SM, Top KA, Hawken S. Vaccine. 2021; 39(15):2117-23. Epub 2021 Mar 13.
Herpes zoster in older adults in Ontario, 2002-2016: investigating incidence and exploring equity
Buchan SA, Daneman N, Wang J, Wilson SE, Garber G, Wormsbecker AE, Antoniou T, Deeks SL. PLoS One. 2021; 16(2):e0246086. Epub 2021 Feb 11.
Assessing the completeness of infant and childhood immunizations within a provincial registry populated by parental reporting: a study using linked databases in Ontario, Canada
Wilson SE, Wilton AS, Young J, Candido E, Bunko A, Buchan SA, Crowcroft NS, Deeks SL, Guttmann A, Halperin SA, Kwong JC, Wilson K, Tu K. Vaccine. 2020; 38(33):5223-30. Epub 2020 Jun 20.